HIF1A and bone sarcoma: A recent meta-analysis of 16 studies (5 in STS) evaluating the prognostic significance of HIF-1α in STS and bone sarcomas found high expression was associated with higher rates of metastases, poor OS and poor DFS (Li et al, 2016).